Alkylating agents in the treatment of nephrotic syndrome.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use*; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D003520:Cyclophosphamide